Form 4: Haemonetics HR SVP Disposes Shares for Tax Obligations
Insider Transaction Report
Haemonetics' SVP of Human Resources, Laurie A. Miller, disposed of 238 shares of common stock to cover tax obligations related to restricted stock unit vesting.
Summary
- Laurie A. Miller, SVP, Human Resources at HAEMONETICS CORP (HAE), reported a transaction on September 17, 2025.
- The transaction involved the disposition of 238 shares of Common Stock.
- These shares were withheld for tax obligations in connection with the vesting of previously reported restricted stock units (RSUs).
- The disposition occurred at a price of $49.95 per share.
- Following this transaction, Ms. Miller beneficially owns 28,925 shares, which includes unvested RSUs.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving shares withheld for tax obligations upon RSU vesting, which is a neutral event and does not reflect positively or negatively on the company's performance or outlook.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This is a routine insider transaction related to compensation and tax obligations, which is common across all industries for executives receiving equity-based awards. It does not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.
- Employees: No direct impact beyond the reporting person, as it relates to individual equity compensation.
Key Dates
| Date | Description |
|---|---|
| 09/17/2025 | Transaction Date for the disposition of shares. |
| 09/24/2025 | Date the Statement of Changes in Beneficial Ownership was signed. |
Recommendation
holdThe filing details a routine insider transaction where shares were withheld to cover tax obligations related to RSU vesting. This is a common occurrence and does not indicate a change in the company's fundamentals or the insider's long-term view, thus a 'hold' recommendation is maintained.
Keywords
Haemonetics, HAE, Form 4, Insider Transaction, Stock Disposition, RSU Vesting, Tax Withholding, Corporate Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.